Parian Global Management LP Axonics, Inc. Transaction History

Parian Global Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$59.21 - $78.66 $5.39 Million - $7.17 Million	-91,100 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $2.89 Million - $3.76 Million	-56,160 Reduced 38.14%	91,100 $5.78 Million
Q4 2020 Feb 16, 2021	SELL	$42.19 - $51.5 $8.67 Million - $10.6 Million	-205,440 Reduced 58.25%	147,260 $7.35 Million
Q3 2020 Nov 16, 2020	BUY	$35.33 - $51.04 $1.15 Million - $1.66 Million	32,475 Added 10.14%	352,700 $18 Million
Q2 2020 Aug 14, 2020	SELL	$22.91 - $39.83 $7.04 Million - $12.2 Million	-307,228 Reduced 48.96%	320,225 $11.2 Million
Q1 2020 May 15, 2020	BUY	$16.44 - $37.73 $4.95 Million - $11.4 Million	301,216 Added 92.33%	627,453 $15.9 Million
Q4 2019 Feb 14, 2020	BUY	$19.57 - $28.96 $5.65 Million - $8.36 Million	288,737 Added 769.97%	326,237 $9.04 Million
Q3 2019 Nov 14, 2019	BUY	$26.92 - $42.41 $1.01 Million - $1.59 Million	37,500 New	37,500 $1.01 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Parian Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Parian Global Management LP with notifications on news.